Participants:

Caleb Bank Senior Product ManagerNuvoAir

Caleb Bank

Senior Product ManagerNuvoAir

Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group

Health Tech & Solutions

Dr. Nick (Nemanja) Kovacev

Head of Healthcare and Life Sciences PracticeHTEC Group

Alexandra Paul Vice President Of Business DevelopmentAccolade, Inc.

Alexandra Paul

Vice President Of Business DevelopmentAccolade, Inc.

Chris Cera CEOArcweb Technologies

Health Tech & Solutions

Chris Cera

CEOArcweb Technologies

Emily Lewis Global Digital Transformation LeadUCB

Emily Lewis

Global Digital Transformation LeadUCB

Eugene Borukhovich Co-Founder & COOYourCoach Health

Startup

Eugene Borukhovich

Co-Founder & COOYourCoach Health

Jim Howard CEOReadout Health

Other

Jim Howard

CEOReadout Health

Kasparas Aleknavicius Medical AdvisorKilo.Health

Other

Kasparas Aleknavicius

Medical AdvisorKilo.Health

Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works

Health Tech & Solutions

Mark Grossman

VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works

Vasyl Pyrozhyk Vice PresidentSMBC

Other

Vasyl Pyrozhyk

Vice PresidentSMBC

About this Meeting

We have seen a significant number of employers starting to incorporate DTx products into their benefits plans (e.g Pear Therapeutics reSET, Freespira, etc). But why is this a good route to market for DTx companies? Is this the first step in the door to start getting real world use of the product to help later explore other avenues? And does it make sense outside the US? Join us in this informal conversation with other peers to discuss:

What products are a good fit for employer partnerships and why? E.g oncology might be less aligned with the employer-focused route to market compared to MSK pain management or other areas.
Real examples of successful DTx-employers partnerships. What can we learn from them?
What are the implications of choosing the employer's route to market? (e.g impact to the evidence generation process, pricing, marketing, organizational structure, etc)
What are employers’ requirements to partner (e.g clinical and economic evidence, usability, etc)? What are the challenges of these partnerships?
Are employees actually engaged with these products?

The Future of Care Delivery: Defining a Real Clinical AI Strategy for What’s Next

How Health Plans Can Close the Gap Between AI Ambition and Data Reality

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass - Big Tech, Big Bets: Where AI in Healthcare Actually Scales

Advancing High-Value Care Through Smarter Decision Support and Population Strategies

Growth in a Contracting Market

The Making of Petunia: Creativity, Risk and the Power of Play

DTx - Employers partnerships

Anchored by:

Participants:

About this Meeting

Featured:

The Future of Care Delivery: Defining a Real Clinical AI Strategy for What’s Next

Sponsored by:

How Health Plans Can Close the Gap Between AI Ambition and Data Reality

Sponsored by:

Featured:

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass - Big Tech, Big Bets: Where AI in Healthcare Actually Scales

Featured:

Advancing High-Value Care Through Smarter Decision Support and Population Strategies

Sponsored by:

Growth in a Contracting Market

Sponsored by:

Featured:

Featured:

The Making of Petunia: Creativity, Risk and the Power of Play

DTx - Employers partnerships

Anchored by:

Participants:

Explore participants

About this Meeting